Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Enzo Biochem Inc (ENZ) Insider Trading Activity
Healthcare • Diagnostics & Research • 179 employees
Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.
Total Value
$20,000.00
Total Shares
428,691
Average Trade Value
$6,666.67
Most Active Insider
Pully Steven J
Total Activity: $10,000
Largest Single Transaction
$10,000
by Pully Steven J on Jan 16, 2025
30-Day Activity
3 Transactions
Volume: 428,691 shares
Value: $20,000
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Director
|
Jan 16, 2025 | 142,897 | $10,000 | 239,992 (+59.5%) | Grant | |
Director
|
Jan 16, 2025 | 142,897 | $0 | 4,533,779 (+3.2%) | Grant | |
Director
|
Jan 16, 2025 | 142,897 | $10,000 | 142,897 (+100.0%) | Grant |